BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20555233)

  • 1. Anesthesia and arrhythmogenesis in the chronic atrioventricular block dog model.
    Dunnink A; Sharif S; Oosterhoff P; Winckels S; Montagne D; Beekman J; van der Nagel R; van der Heyden MA; Vos MA
    J Cardiovasc Pharmacol; 2010 Jun; 55(6):601-8. PubMed ID: 20555233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular remodelling is a prerequisite for the induction of dofetilide-induced torsade de pointes arrhythmias in the anaesthetized, complete atrio-ventricular-block dog.
    Dunnink A; van Opstal JM; Oosterhoff P; Winckels SK; Beekman JD; van der Nagel R; Cora Verduyn S; Vos MA
    Europace; 2012 Mar; 14(3):431-6. PubMed ID: 21946817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vernakalant is devoid of proarrhythmic effects in the complete AV block dog model.
    Varkevisser R; van der Heyden MA; Tieland RG; Beekman JD; Vos MA
    Eur J Pharmacol; 2013 Nov; 720(1-3):49-54. PubMed ID: 24211677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsade de pointes and sudden death induced by thiopental and isoflurane anesthesia in dogs with cardiac electrical remodeling.
    Zhou S; Cao JM; Ohara T; KenKnight BH; Chen LS; Karagueuzian HS; Chen PS
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7(1):39-43. PubMed ID: 12000977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of K201 on repolarization and arrhythmogenesis in anesthetized chronic atrioventricular block dogs susceptible to dofetilide-induced torsade de pointes.
    Stams TR; Oros A; der Nagel Rv; Beekman JD; Chamberlin P; Dittrich HC; Vos MA
    Eur J Pharmacol; 2011 Dec; 672(1-3):126-34. PubMed ID: 22001562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block.
    Oros A; Volders PG; Beekman JD; van der Nagel T; Vos MA
    Heart Rhythm; 2006 Nov; 3(11):1339-45. PubMed ID: 17074641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation-influences of anesthesia and validation with quinidine and astemizole.
    Yamamoto K; Tamura T; Imai R; Yamamoto M
    Toxicol Sci; 2001 Mar; 60(1):165-76. PubMed ID: 11222883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beat-to-Beat Variability in Preload Unmasks Latent Risk of Torsade de Pointes in Anesthetized Chronic Atrioventricular Block Dogs.
    Stams TR; Oosterhoff P; Heijdel A; Dunnink A; Beekman JD; van der Nagel R; van Rijen HV; van der Heyden MA; Vos MA
    Circ J; 2016 May; 80(6):1336-45. PubMed ID: 27151565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I
    van Bavel JJA; Beekman HDM; van Weperen VYH; van der Linde HJ; van der Heyden MAG; Vos MA
    Eur J Pharmacol; 2022 Oct; 932():175218. PubMed ID: 36007604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The electromechanical window is no better than QT prolongation to assess risk of Torsade de Pointes in the complete atrioventricular block model in dogs.
    Stams TR; Bourgonje VJ; Beekman HD; Schoenmakers M; van der Nagel R; Oosterhoff P; van Opstal JM; Vos MA
    Br J Pharmacol; 2014 Feb; 171(3):714-22. PubMed ID: 24490860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model.
    Antoons G; Oros A; Beekman JD; Engelen MA; Houtman MJ; Belardinelli L; Stengl M; Vos MA
    J Am Coll Cardiol; 2010 Feb; 55(8):801-9. PubMed ID: 20170820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Istaroxime, a positive inotropic agent devoid of proarrhythmic properties in sensitive chronic atrioventricular block dogs.
    Bossu A; Kostense A; Beekman HDM; Houtman MJC; van der Heyden MAG; Vos MA
    Pharmacol Res; 2018 Jul; 133():132-140. PubMed ID: 29753687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation.
    Thomsen MB; Oros A; Schoenmakers M; van Opstal JM; Maas JN; Beekman JD; Vos MA
    Cardiovasc Res; 2007 Feb; 73(3):521-30. PubMed ID: 17196569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced torsade de pointes arrhythmias in the chronic AV block dog are perpetuated by focal activity.
    Boulaksil M; Jungschleger JG; Antoons G; Houtman MJ; de Boer TP; Wilders R; Beekman JD; Maessen JG; van der Hulst FF; van der Heyden MA; van Veen TA; van Rijen HV; de Bakker JM; Vos MA
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):566-76. PubMed ID: 21622813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
    van Opstal JM; Schoenmakers M; Verduyn SC; de Groot SH; Leunissen JD; van Der Hulst FF; Molenschot MM; Wellens HJ; Vos MA
    Circulation; 2001 Nov; 104(22):2722-7. PubMed ID: 11723026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological parameters indicative of sudden cardiac death in the dog with chronic complete AV-block.
    van Opstal JM; Verduyn SC; Leunissen HD; de Groot SH; Wellens HJ; Vos MA
    Cardiovasc Res; 2001 May; 50(2):354-61. PubMed ID: 11334839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-septal pacing reduces ventricular electrical remodeling and proarrhythmia in chronic atrioventricular block dogs.
    Winckels SK; Thomsen MB; Oosterhoff P; Oros A; Beekman JD; Attevelt NJ; Kretzers L; Vos MA
    J Am Coll Cardiol; 2007 Aug; 50(9):906-13. PubMed ID: 17719479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced ventricular proarrhythmic potential of the novel combined ion-channel blocker AZD1305 versus dofetilide in dogs with remodeled hearts.
    Johnson DM; de Jong MM; Crijns HJ; Carlsson LG; Volders PG
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):201-9. PubMed ID: 22080293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective late sodium current inhibitor GS-458967 suppresses Torsades de Pointes by mostly affecting perpetuation but not initiation of the arrhythmia.
    Bossu A; Houtman MJC; Meijborg VMF; Varkevisser R; Beekman HDM; Dunnink A; de Bakker JMT; Mollova N; Rajamani S; Belardinelli L; van der Heyden MAG; Vos MA
    Br J Pharmacol; 2018 Jun; 175(12):2470-2482. PubMed ID: 29582428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing the infusion rate reduces the proarrhythmic risk of NS-7: confirming the relevance of short-term variability of repolarisation in predicting drug-induced torsades de pointes.
    Detre E; Thomsen MB; Beekman JD; Petersen KU; Vos MA
    Br J Pharmacol; 2005 Jun; 145(3):397-404. PubMed ID: 15778734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.